Trinity Biotech

TRIB · NASDAQ

$7.79−$0.40 (−4.88%)TodayMarket closed ·
Prev close $8.19

Latest news

  • Press releaseGlobe Newswire

    Trinity Biotech Partners with Latch Medical to Advance Biosensor-Guided Precision Drug Delivery Solutions Using CGM+ Technology

  • Press releaseGlobe Newswire

    New Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem by Going Beyond Glucose-Only Monitoring

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • Press releaseGlobe Newswire

    Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • Press releaseGlobe Newswire

    Trinity Biotech Appoints Jerry Lydon to Lead North America Commercial Operations

  • NewsAvi Kapoor

    Why Kyverna Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • Press releaseGlobe Newswire

    Trinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next-Generation Premier Hb9210 HbA1c Column System

  • Press releaseGlobe Newswire

    Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform

  • Press releaseGlobe Newswire

    Trinity Biotech Provides Business and Trading Update

  • News

    Trinity Biotech Obtains Full Regulatory Approval For The Commencement Of Upstream Manufacturing Activities For Its Flagship WHO Prequalified Uni-Gold HIV Rapid Test Under The Company's Offshored And Outsourced Production Model

  • Press releaseGlobe Newswire

    Trinity Biotech Secures Regulatory Approval for Commencement of Upstream Manufacturing Activities of Uni-Gold™ HIV Rapid Test Under Its Offshored and Outsourced Model, Supporting Financial Performance Transformation

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • NewsShivdeep Dhaliwal

    Indaptus Therapeutics, Uipath, Trinity Biotech, Sable Offshore And McDonald's: Why These 5 Stocks Are On Investors' Radars Today

  • NewsAvi Kapoor

    Dow Gains 100 Points; US Durable Goods Orders Decline In October

  • NewsAvi Kapoor

    US Stocks Mixed; GDP Growth Tops Expectations

  • NewsAkanksha Bakshi

    Why Is Trinity Biotech Stock Soaring Tuesday?

  • Press releaseGlobe Newswire

    Trinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV Tests

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Friday's After-Market Session

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's Intraday Session

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • Press releaseGlobe Newswire

    Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029

  • NewsDylan Berman

    What's Going On With Trinity Biotech Shares Tuesday?

  • News

    Insights Ahead: Trinity Biotech's Quarterly Earnings

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • News

    Market-Moving News for August 27th

  • NewsAvi Kapoor

    Why Trip.com Group Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.